Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Macro

Why China’s Biggest Rate Cut Ever Signals Major Economic Shifts

by Team Lumida
September 25, 2024
in Macro
Reading Time: 4 mins read
A A
0
China’s Financial Overhaul: Xi’s Strategy to Rebalance $9.1 Trillion Debt Crisis
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

  1. China slashes one-year policy rate by 30 basis points to 2%.
  2. Stimulus measures aim to achieve 5% growth goal amidst deflation fears.
  3. Expect further rate cuts and liquidity injections in coming months.

What Happened?

China’s central bank, the People’s Bank of China (PBOC), cut the interest rate on its one-year policy loans by 30 basis points to 2%, the largest reduction since the monetary tool’s inception in 2016. This move is part of a broader stimulus package announced by Governor Pan Gongsheng aimed at rejuvenating the world’s second-largest economy.

The yuan surged past 7 per dollar for the first time in 16 months, while Chinese stocks continued to climb, and the yield on China’s 10-year bonds dropped to 2.05%. The reduction in the medium-term lending facility (MLF) rate is a precursor to additional measures, including a 20 basis point cut on seven-day reverse repurchase notes.

Why It Matters?

This rate cut is a crucial step in China’s strategy to combat a potential deflationary spiral and meet its approximately 5% growth target for the year. The move signals a more aggressive monetary policy stance, aiming to boost market confidence and economic activity. Bruce Pang, chief economist for Greater China at Jones Lang LaSalle Inc., emphasized the importance of the strength, frequency, and synergy of upcoming measures.

Additionally, the PBOC’s actions have already impacted financial markets, with the yuan appreciating and stock indices recovering losses. Investors should note that these steps are designed to stabilize borrowing costs and enhance liquidity, which could lead to increased consumer spending and business investment.

What’s Next?

Investors can expect further rate cuts and liquidity injections as the PBOC plans to replace MLF liquidity with tools like reserve requirement ratio (RRR) cuts. The central bank aims to unleash 1 trillion yuan in long-term liquidity by reducing the RRR by 50 basis points. Strategists like Frances Cheung from Oversea-Chinese Banking Corp. anticipate more MLF replacement in the coming months, given the significant MLF maturities ahead.

The earliest implementation of the repo rate cut might occur after the National Day holiday starting October 1. Additionally, the PBOC’s new approach allows banks to influence MLF prices by bidding on interest rates, reflecting a shift towards a more market-driven mechanism.

Additional Considerations:

China’s aggressive stimulus measures could set a precedent for other central banks grappling with similar economic challenges. Investors should monitor the PBOC’s next moves closely, as these will provide further insights into China’s economic health and policy direction. The market’s reaction to these measures will offer valuable clues about future trends in global finance and investment opportunities.

Source: Bloomberg
Tags: China
Previous Post

Intel Receives Massive Apollo Offer Amid Qualcomm Interest

Next Post

US Futures Dip: What’s Next After S&P 500’s Record Close?

Recommended For You

Dollar Steadies, Euro and Sterling Vulnerable as Markets Await Fed Decision; Bitcoin Trades at 4-Week Lows

by Team Lumida
4 hours ago
Dollar Steadies, Euro and Sterling Vulnerable as Markets Await Fed Decision; Bitcoin Trades at 4-Week Lows

Currencies position ahead of Fed rate hike; dollar strength pressures EUR, GBP, AUD; Bitcoin at $75,886 after Clarity Act fails; forward guidance key to currency moves.

Read more

Bank of England Eyes End to Long-Dated Bond Sales as 30-Year Gilts Approach 6%, Shifting Quantitative Tightening Strategy

by Team Lumida
1 day ago
Bank of England Eyes End to Long-Dated Bond Sales as 30-Year Gilts Approach 6%, Shifting Quantitative Tightening Strategy

The BOE may cease selling 20 and 30-year bonds despite heavy losses, marking a reversal of recent messaging as energy prices and inflation expectations pressurize sterling debt.

Read more

10-Year Treasury Yield Hits 5.025%, Highest Since 2007, as Markets Price 92% Odds of Fed Hike

by Team Lumida
1 day ago
10-Year Treasury Yield Hits 5.025%, Highest Since 2007, as Markets Price 92% Odds of Fed Hike

The 10-year yield surged to 5.025% as inflation remains above the Fed's target, with traders betting heavily on a 25-basis-point rate increase this week.

Read more

BIS Warns Leveraged Hedge Funds Pose Growing Systemic Risk After Situational Awareness Near-Collapse

by Team Lumida
2 days ago
BIS Warns Leveraged Hedge Funds Pose Growing Systemic Risk After Situational Awareness Near-Collapse

The Bank for International Settlements flagged the July near-collapse of Leopold Aschenbrenner's AI-focused hedge fund as evidence that leveraged funds have become a core financial stability risk.

Read more

Study Finds Trump’s Drug-Pricing Push Incentivizes Higher Prices and Reduced Access Outside the US

by Team Lumida
2 days ago
Study Finds Trump’s Drug-Pricing Push Incentivizes Higher Prices and Reduced Access Outside the US

A Lancet study found that for roughly three in four drugs studied, matching US Medicare prices to cheaper reference countries would cost companies more than they earn in...

Read more

Chevron Says It Needs EU Methane Rule Clarity Before Committing to LNG Import Infrastructure

by Team Lumida
2 days ago
Chevron Says It Needs EU Methane Rule Clarity Before Committing to LNG Import Infrastructure

Chevron is weighing investment in European LNG regasification capacity but wants clearer methane regulations before making long-term commitments, its global gas president said.

Read more

Russia Outpaces US and NATO on Cheap Weapons Production, Fueled by Chinese Components

by Team Lumida
2 days ago
Russia Outpaces US and NATO on Cheap Weapons Production, Fueled by Chinese Components

Russia has fielded new Geran drones and Banderol cruise missiles at roughly $100,000 each, built on Chinese electronics, faster than Ukraine or Western militaries can match.

Read more

10-Year Treasury Yield Holds Near 4.97% as Markets Price 86.7% Odds of a Fed Hike This Week

by Team Lumida
2 days ago
Lumida Wealth Whale Watch Q2’24 : Macro Funds

Treasury yields were little changed Monday as investors weighed whether a move above 5% on the 10-year would come from healthy growth or from stress in the bond...

Read more

BMO and Sun Life Commit C$75 Billion to Canada’s Infrastructure Build, Days Before Carney’s Toronto Investor Summit

by Team Lumida
5 days ago
BMO and Sun Life Commit C$75 Billion to Canada’s Infrastructure Build, Days Before Carney’s Toronto Investor Summit

BMO pledged up to C$70 billion over a decade and Sun Life C$5 billion for Canadian infrastructure, ahead of Mark Carney's investor summit in Toronto.

Read more

10-Year Treasury Yield Hits 4.94%, Closest to 5% Since 2023 as Traders Price 70% Odds of a September Fed Hike

by Team Lumida
5 days ago
Saudi Arabia Leads $321B EM Bond Spree: What Investors Need to Know

The 10-year Treasury yield climbed to 4.94% ahead of August CPI, with traders pricing roughly 70% odds of a Fed rate hike on Sept. 16.

Read more
Next Post
S&P 500’s Big Earnings Test: Will Tech Slowdown Derail Gains?

US Futures Dip: What's Next After S&P 500's Record Close?

a computer keyboard with a blue light on it

California's AI Bill: What Business Tech Leaders Are Saying

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Trump Fires BLS Chief After Weak Jobs Report, Eyes More Fed Influence

Trump Considers National Housing Emergency

September 2, 2025
Trump Tariffs Leave Key Questions on China Supply Chain Rules Unanswered

Trump Calls for European Troops in Ukraine; Public and Political Support Across Europe Is Tepid

August 27, 2025
a white square with a blue logo on it

Meta Doubles Down on AI Wearables With Limitless Acquisition

December 6, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018